Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients? - Wikidata - wikimedia - TriplyDB

Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?

Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?

http://www.wikidata.org/entity/Q37579527

about

Recent advances in the understanding and management of mucormycosis

P2860

Q57116582-3B0DA601-A034-4701-A9AF-AE1A7AB9F66A

P2860

Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?

http://www.wikidata.org/entity/Q37579527

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Is It Time to Include CT "Reve ...... rmycosis in Leukemia Patients?

@en

Is It Time to Include CT "Reve ...... rmycosis in Leukemia Patients?

@nl

type

label

Is It Time to Include CT "Reve ...... rmycosis in Leukemia Patients?

@en

Is It Time to Include CT "Reve ...... rmycosis in Leukemia Patients?

@nl

prefLabel

Is It Time to Include CT "Reve ...... rmycosis in Leukemia Patients?

@en

Is It Time to Include CT "Reve ...... rmycosis in Leukemia Patients?

@nl

P1433

Q37579527-95BAEF80-C16D-4C09-9502-03E16A994162

P1476

Q37579527-643979D4-B06F-4243-9B79-84AB33F5BE05

P2093

Q37579527-15000829-EC92-4669-B42F-541F41140713

Q37579527-182B5760-F9EC-4E84-A03C-7F0ADC5CF0CE

Q37579527-2E6FE73C-A936-4BCB-9E45-8C5D130C04E8

Q37579527-33DB191A-15F9-4FD7-B7B9-29A84FB4499F

Q37579527-4C25F2D3-FCD4-4610-955D-955365F66F5B

Q37579527-50536511-8790-4DB2-A944-70C0F4AA7963

Q37579527-52D2CA65-93AE-49BE-B0BF-01B0A585C462

Q37579527-80638D60-A554-4784-AF10-F3E95412B522

Q37579527-C7C30712-2038-4E23-AF3C-2C38607928C3

Q37579527-CB432BB4-B1F9-4C9E-96AA-FBFD9AC6A1DB

P2860

Q37579527-0C564CB7-5863-4642-B882-877ADDF42EBC

Q37579527-1FCAA95B-6FFC-4A62-9A9D-4DDA72FE5233

Q37579527-38E4A813-1C9E-4C22-8F21-A3236F96B0A4

Q37579527-5046B223-B9CC-40E6-8CD4-8C8FF478AC06

Q37579527-69504A9F-8ED0-4DCE-96F5-3C952B0F8A2C

Q37579527-6D736A30-1459-418D-ADF8-6A689A995ED7

Q37579527-7BB442A8-E8EC-4622-A1E0-E271BC6714FD

Q37579527-B362752B-49F9-4819-BB01-C4169CA22B31

Q37579527-C40AC97D-65CD-41EB-9A8C-1372EA2781BE

Q37579527-CB966E40-BE37-4FBB-9AE6-6BDA8A91E3B5

P304

Q37579527-826DEB5F-FD1C-4989-B71C-D0C6DA526608

P31

Q37579527-9E9D57C7-D632-4F51-B8A6-B17F93935B86

P356

Q37579527-A695F2A3-229C-44B5-A055-C3DBF7B4D152

P433

Q37579527-31EF945F-FD2A-47D7-99DC-D68230C81C12

P478

Q37579527-43CA13DD-9A42-4F6F-AAA7-58AD6266EAB0

P577

Q37579527-11DDCA59-1BA1-403A-88D1-D6AD1B9E66B1

P698

Q37579527-804EF09E-64FF-44ED-82C1-869BB5CFFEF9

P921

Q37579527-688E8FEE-5F48-47BE-BF7F-7A526C955A9C

P932

Q37579527-6F5CB595-10F7-485E-9D2F-E0C2F8FF9684

P356

P1433

Open forum infectious diseases

P1476

Is It Time to Include CT "Reve ...... rmycosis in Leukemia Patients?

@en

P2093

Alexandre Payssot

http://www.w3.org/2001/XMLSchema#string

Caroline Legouge

http://www.w3.org/2001/XMLSchema#string

Denis Caillot

http://www.w3.org/2001/XMLSchema#string

Frédéric Dalle

http://www.w3.org/2001/XMLSchema#string

Ingrid Lafon

http://www.w3.org/2001/XMLSchema#string

Laurence Million

http://www.w3.org/2001/XMLSchema#string

Louise Basmaciyan

http://www.w3.org/2001/XMLSchema#string

Marc Sautour

http://www.w3.org/2001/XMLSchema#string

Marie Lorraine Chretien

http://www.w3.org/2001/XMLSchema#string

Stéphane Valot

http://www.w3.org/2001/XMLSchema#string

P2860

Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data.

Increasing incidence of mucormycosis in University Hospital, Belgium.

Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Epidemiology and clinical manifestations of mucormycosis.

Mucormycosis in organ and stem cell transplant recipients.

Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).

Impact of zygomycosis on microbiology workload: a survey study in Spain.

Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.

The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?

P304

ofw190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFW190

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28101518

http://www.w3.org/2001/XMLSchema#string

P921

P932

5225907

http://www.w3.org/2001/XMLSchema#string